Many companies have been involved in cloning animals, often in collaboration
with researchers at universities. Some of them have come and gone or been bought out as cloning technologies mature and move in new directions. I've listed here in alphabetical order
some of the major companies performing cloning research and some that were important but have now closed. Press release news, patent information,
and publications can be found on these sites.
- Advanced Cell Technologies
(ACT).11100 Santa Monica Blvd., #850,
Los Angeles, CA 90025
This company successfully cloned calves and an endangered ox, the
guar. They are the only company in the United States to openly pursue
the highly controversial therapeutic human embryo cloning. They also
are focusing a lot of their research on human embryonic stem cells
and towards that end moved their headquarters to California,
where voters passed Proposition 71, a Stem Cell Initiative
that provides $3.0 billion of funding over the next ten years for
stem cell research in the state of California. Press releases are
on the Web page. In 2007 they acquired their former competitor company, Infigen, which cloned pigs and cattle and received a critical patent for the nuclear transfer process.
- L'Alliance Boviteq (LAB) 1425,
grand rang Saint-François, Saint-Hyacinthe (Québec), Canada
In September, 2000, this company cloned a famous Holstein bull in
collaboration with the University of Montreal Veterinary Faculty.
This was the first cloning of an animal from an adult somatic cell
- Cyagra 197 Bossler Rd., Elizabethtown,
A premier livestock cloning company that has produced hundreds of
cloned calves. PerPETuate,
a pet cell banking company, is in partnership with Cyagra, using the
cell banking technology to store cells from pets in hopes that one
day pet cloning will be technically possible.
- Genetic Savings and Clone (closed in 2006)
This company had a development agreement with Texas A&M University and
invested money particularly in research for cloning dogs and cats in order to have a business cloning people's pets. They worked on the "CopyCat project"
which funded the successful creation of a cat clone in February 2002.
The fact that the cloned cat was not identical to the donor cat was
relations problem for the company. The dog cloning technology was not successful, and the company is now closed.
Other companies such as Viagen
and PerPETuate (see above) are gene banking pets in hopes that cloning
will be possible some day
- Geron Corporation Menlo Park,
Geron acquired Roslin Bio-Med (a company formed by the Roslin Institute)
in 1999 and now owns their patents on the nuclear transfer process.
A list of their patents is available under their Product Development
link. One of their focuses now is human embryonic stem cell research.
- Lazaron BioTechnologies (SA), Ltd.c/o John Daniel House, PO Box 1243 , Stellenbosch, 7599, Republic of South Africa
Formerly in the United States, but currently established as a South African Biotechnology Company, Lazaron now focuses on regenerative cell technologies. Their Animal Bio-cell Division does store genetic material from wildlife, livestock and pets for future cloning procedures,
however, this is only one of their many projects. Much of their work is with stem cells.
Therapeutics Scotland, U.K. (closed)
This company collaborated with the Roslin Institute in the original
cloning of Dolly. They were particularly interested in creating cloned
animals carrying new proteins in their milk for the purpose of curing
human disease. They cloned Polly, a sheep who carried a human
gene to treat hemophilia B, and also cloned cows and pigs.
nuclear transfer patents were sold to Exeter Life Sciences in 2004.
- The Roslin Institute Scotland,
This is the research institute at which Ian Wilmut and his research
group originally cloned Dolly in collaboration with PPL Therapeutics,
see above. Geron (see above) has now acquired their patents. The
Roslin Institute Web site includes a public
interest section on cloning.
12357-A Riata Trace Parkway, Suite 100,
Austin, Texas 78727
ViaGen was founded in 2002 to provide commercial bovine, equine, and porcine gene banking, cloning, and genomics services. Their cloning technologies were the ones developed in part by scientists at Texas A&M University.
In 2003, ViaGen acquired ProLinia of Athens, Georgia, and ProLinia's non exclusive license from Geron (see above) for nuclear transfer technology.